• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Successful treatment with bortezomib, thalidomide and dexamethasone in plasma cell myeloma post-bone marrow transplant.

作者信息

Cao Yaqing, Shang Jingjing, Zhai Yingying, Wang Qingyuan, Yan Lingzhi, Shi Xiaolan, Wang Jing, Yao Ying, Zhou Huifen, Sun Aining, Miao Miao, Fu Chengcheng, Jin Song

机构信息

National Clinical Research Centre for Haematologic Diseases, Jiangsu Institute of Haematology, The First Affiliated Hospital of Soochow University, Suzhou, China.

Institute of Blood and Marrow Transplantation, Collaborative Innovation Centre of Haematology, Soochow University, Suzhou, China.

出版信息

Leuk Lymphoma. 2024 Jul;65(7):1016-1019. doi: 10.1080/10428194.2024.2329322. Epub 2024 Apr 1.

DOI:10.1080/10428194.2024.2329322
PMID:38557299
Abstract
摘要

相似文献

1
Successful treatment with bortezomib, thalidomide and dexamethasone in plasma cell myeloma post-bone marrow transplant.硼替佐米、沙利度胺和地塞米松成功治疗骨髓移植后浆细胞骨髓瘤。
Leuk Lymphoma. 2024 Jul;65(7):1016-1019. doi: 10.1080/10428194.2024.2329322. Epub 2024 Apr 1.
2
Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study.硼替佐米、沙利度胺和地塞米松（VTD）作为多发性骨髓瘤移植前诱导治疗的优势：一项随机 3 期 PETHEMA/GEM 研究。
Blood. 2012 Aug 23;120(8):1589-96. doi: 10.1182/blood-2012-02-408922. Epub 2012 Jul 12.
3
Subcutaneous bortezomib incorporated into the bortezomib-thalidomide-dexamethasone regimen as part of front-line therapy in the context of autologous stem cell transplantation for multiple myeloma.皮下注射硼替佐米纳入硼替佐米-沙利度胺-地塞米松方案，作为多发性骨髓瘤自体干细胞移植一线治疗的一部分。
Haematologica. 2014 Mar;99(3):e33-4. doi: 10.3324/haematol.2013.100396. Epub 2014 Feb 14.
4
Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma.硼替佐米联合地塞米松与低剂量硼替佐米、沙利度胺联合地塞米松作为新诊断多发性骨髓瘤患者自体干细胞移植前的诱导治疗。
Blood. 2011 Nov 24;118(22):5752-8; quiz 5982. doi: 10.1182/blood-2011-05-355081. Epub 2011 Aug 17.
5
Combination of bortezomib, thalidomide, and dexamethasone in the treatment of relapsed, refractory IgD multiple myeloma.硼替佐米、沙利度胺和地塞米松联合治疗复发难治性IgD型多发性骨髓瘤
Leuk Lymphoma. 2005 Apr;46(4):567-9. doi: 10.1080/10428190400029700.
6
Scleromyxedema and dermato–neuro syndrome in a patient with multiple myeloma effectively treated with dexamethasone and bortezomib.一名多发性骨髓瘤患者的硬化性黏液水肿和皮肤-神经综合征经地塞米松和硼替佐米有效治疗。
Am J Hematol. 2011 Oct;86(10):893-6. doi: 10.1002/ajh.22131.
7
Phase I trial of first-line bortezomib/thalidomide plus chemotherapy for induction and stem cell mobilization in patients with multiple myeloma.硼替佐米/沙利度胺一线治疗联合化疗用于多发性骨髓瘤患者诱导及干细胞动员的I期试验
Clin Lymphoma Myeloma. 2006 Nov;7(3):210-6. doi: 10.3816/CLM.2006.n.061.
8
Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial.序贯长春新碱、阿霉素、地塞米松（VAD）方案联合硼替佐米、沙利度胺、地塞米松（VTD）方案诱导，大剂量化疗联合自体造血干细胞移植巩固治疗初治多发性骨髓瘤的Ⅱ期临床研究。
Ann Hematol. 2012 Feb;91(2):249-56. doi: 10.1007/s00277-011-1298-9. Epub 2011 Jul 26.
9
"IM iD"eally treating multiple myeloma.“IM iD”真的能治疗多发性骨髓瘤。
Blood. 2013 Mar 14;121(11):1926-8. doi: 10.1182/blood-2013-01-476267.
10
Pegylated liposomal doxorubicin in combination with dexamethasone and bortezomib (VMD) or lenalidomide (RMD) in multiple myeloma pretreated patients.聚乙二醇化脂质体阿霉素联合地塞米松和硼替佐米（VMD方案）或来那度胺（RMD方案）用于多发性骨髓瘤预处理患者。
Ann Hematol. 2011 Sep;90(9):1115-6. doi: 10.1007/s00277-010-1136-5. Epub 2010 Dec 22.